Company intelligence / Profile preview

Aster Insights

Tampa, Florida, United Statesasterinsights.com ↗

Ownership: Private
Development stage: Commercial

Overview

Aster Insights is a leading provider of scientific and clinical intelligence for oncology, supporting the discovery and development of cancer therapies. Through its ORIEN consortium and TCC study, it has enabled over 150 research collaborations, contributed to more than 100 publications, and supported major drug developments such as KEYTRUDA®[2]. The company’s platform connects patient data with researchers to accelerate biomarker discovery, trial recruitment, new indication identification, and improved outcomes across the cancer care continuum[1][2][3].

Therapeutic areas: Oncology
Industry: Drug Discovery Services

Partnerships

ORIEN member institutions (18 leading US cancer centers)Academic medical centersPharmaceutical companies including Merck (notably supported KEYTRUDA® development)

Beyond the preview

Go deeper on Aster Insights.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aster Insights.

Explore the full profile